Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: IA NONMETROPOLITAN AREA — September 2026
Nonmetro Iowa pays a premium for scarce clinical and QA talent.
Clinical Research Associate advertised pay in the metro area hit $106,222 — above the $90,956 national median — as Iowa's 3.2% unemployment rate and retirement-driven labor exits squeeze an already thin rural scientific talent pool.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Iowa unemployment rate: 3.2% — Unchanged for 4th straight month, Aug 2026
- CRA advertised pay, metro vs national: $106,222 vs $90,956 — Metro exceeds national median, reversed discount
- Iowa 12-month job change: -9,500 jobs (-0.6%) — vs +0.3% national growth; ranks 46th of 50 states
- Validation Engineer advertised pay, metro: $121,331 — vs $108,377 national median
Key takeaways
Validation Engineer pay is outrunning the national trend here.
Metro median advertised pay for Validation Engineer sits at $121,331, above the $108,377 national figure, pointing to acute local scarcity in quality/manufacturing support roles tied to Iowa's ongoing manufacturing job gains. Employers competing for this talent should expect continued upward pressure as device and biologics manufacturing investment persists.
Clinical Research Associate advertised pay now exceeds national levels.
Metro median CRA pay of $106,222 versus a $90,956 national median is a reversal of the usual rural discount and suggests a genuinely constrained local clinical talent supply rather than a one-off posting anomaly. Compensation teams should treat this as a signal to re-benchmark clinical roles against current postings, not legacy survey data.
Regulatory Affairs pay gap with the national market is widening.
Metro Regulatory Affairs Specialist pay sits roughly $14,000 below the national median while demand for regulatory expertise intensifies nationally amid EU MDR and FDA pathway changes. Organizations may struggle to retain mid-career regulatory talent locally without closing this gap or building remote/hybrid flexibility into these roles.
Retirement-driven labor exits are a quiet threat to R&D continuity.
Iowa's working population fell 7,500 year-over-year, driven largely by retirements, which disproportionately affects institutional knowledge in long-tenured scientific and manufacturing roles common at employers like Boehringer Ingelheim Vetmedica. Succession planning and knowledge transfer may need to move up the priority list ahead of further headcount actions.
Median advertised pay by role — IA NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $102,932 | $109,259 | $113,108 | Significant increase | $131,354 |
| Clinical Research Associate * | $57,200 | $106,222 | $125,628 | Significant increase | $90,956 |
| Lab Technician | $40,180 | $50,554 | $54,649 | Significant increase | $47,402 |
| Regulatory Affairs Specialist * | $74,639 | $90,187 | $103,011 | Significant increase | $104,000 |
| Clinical Data Manager * | $74,125 | $89,187 | $112,693 | Significant decline | $123,031 |
| Biostatistician * | $86,372 | $110,253 | $146,269 | Moderate decline | $133,322 |
| Validation Engineer * | $118,498 | $121,331 | $123,498 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Nonmetropolitan Iowa labor markets remain structurally tight, with statewide unemployment holding at 3.2% for a fourth straight month even as the state shed 9,500 jobs over the past year and working-age population declined amid retirements. Manufacturing added 1,300 jobs in August and healthcare continued double-digit sector growth, but rural counties outside the six designated metro areas face a shrinking labor pool with little inbound migration to offset exits from skilled technical and scientific occupations.
What it means
Thin rural talent pools and an aging workforce exit push Life Sci employers with manufacturing or QA footprints in nonmetro Iowa toward harder build-vs-outsource calculus, since backfilling specialized CMC, quality, and regulatory roles locally takes longer and costs more than in Ames, Iowa City, or Des Moines. Advertised pay for Validation Engineer and Clinical Research Associate roles in the metro area is rising faster than national medians, suggesting employers are already bidding aggressively for a small local candidate pool rather than relying on organic hiring. Organizations should evaluate whether critical validation, QA, and CMC headcount in nonmetro facilities can be right-sized through CDMO partnerships or regional hub consolidation rather than continued local recruitment.
Looking ahead
Early indicator: Watch whether Iowa's new Career Training Physical Expansion Grants, launched September 15, begin feeding a mid-skill QA and manufacturing technician pipeline into nonmetro facilities over the next two quarters.
Emerging pressure point: Manufacturing WARN activity (Winnebago Industries, Forest City) alongside continued manufacturing job growth statewide suggests uneven conditions by employer rather than sector-wide softening — monitor whether released manufacturing talent has transferable skills for CDMO or device production roles.
Worth watching: Biostatistician advertised pay fell moderately in the metro while rising nationally, a divergence worth tracking to determine whether it reflects a thinning local requisition pool or genuine softening demand.
Potential inflection point: National biopharma layoffs (BioMarin, Bristol Myers) paired with 64% of organizations still actively recruiting suggests displaced specialized talent may become available for remote or hybrid regulatory and CMC roles serving nonmetro Iowa employers.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.